Paediatric Respiratory Reviews
Volume 4, Issue 1 , Pages 9-14 , March 2003

Oxygen monitoring in preterm babies: too high, too low?

  • Win Tin

      Affiliations

    • Consultant Paediatrician and Neonatologist, Department of Paediatrics and Neonatal Medicine, The James Cook University Hospital, Middlesbrough, UK
    • Corresponding Author InformationCorrespondence to: Win Tin. Tel.: +44-1642-854834; Fax: +44-1642-854830
    • ,
  • Sue Walker

      Affiliations

    • Advanced Neonatal Nurse Practitioner, Department of Paediatrics and Neonatal Medicine, The James Cook University Hospital, Middlesbrough, UK
    • ,
  • Camilla Lacamp

      Affiliations

    • Clinical Fellow in Paediatrics and Neonatology, Department of Paediatrics and Neonatal Medicine, The James Cook University Hospital, Middlesbrough, UK

References 

  1. Patz A, Hoeck LE, de la Cruz E. Studies on the effect of high oxygen administration in retrolental fibroplasia. 1. Nursery observations. Am. J. Ophthalmol. 1952;35:1248–1253
  2. Kinsey VE, Jacobus JT, Hemphill F. Retrolental fibroplasia: cooperative study of retrolental fibroplasia and the use of oxygen. Arch. Ophthalmol. 1956;56:481–543
  3. Campbell K. Intensive oxygen therapy as a possible cause of retrolental fibroplasia: a clinical approach. Med. J. Austr. 1951;ii:48–50
  4. Crosse VM, Evans PJ. Prevention of retrolental fibroplasia. Arch. Ophthalmol. 1952;48:83–87
  5. Kinsey VE, Arnold HJ, Kalina RE, et al.  PaO2 levels and retrolental fibroplasia. Pediatrics. 1977;60:655–668
  6. Usher R. Treatment of respiratory distress. In: Winters RW (ed.) Body Fluids in Pediatrics. Boston: Little, Brown, 1973; 303–337.
  7. Les Chermignonards Désenchantés. Oxygen and retrolental fibroplasia. Pediatrics 1977; 60: 753–754; see also 1978; 62: 439–440.
  8. Guy LP, Lanman TJ, Dancis J. The possibility of total elimination of retrolental fibroplasia by oxygen restriction. Pediatrics. 1956;17:247–249
  9. Avery ME, Oppenheimer EH. Recent increase in mortality in hyaline membrane disease. J. Pediatr. 1960;57:553–559
  10. Cross KW. Cost of preventing retrolental fibroplasia?. Lancet. 1973;ii:954–956
  11. Bolton DPG, Cross KW. Further observations on the cost of preventing retrolental fibroplasia. Lancet. 1974;i:445–448
  12. Duc G, Sinclair JC. Oxygen administration. In: Sinclair JC, Bracken MB (eds.) Effective Care of the Newborn Infant. Oxford: Oxford University Press, 1992; 178–199.
  13. Flynn JT, Bancalari E, Bawol R, et al.  Retinopathy of prematurity. A randomized prospective trial of transcutaneous oxygen monitoring. Ophthalmology. 1987;94:630–638
  14. Flynn JT, Bancalari E, Snyder ES et al. A cohort study of transcutaneous oxygen tension and the incidence and severity of retinopathy of prematurity. N Engl J Med 1992; 326: 1050–1054; see also 1078–1080.
  15. Nicolini U, Nicolaidis P, Fisk NM, et al.  Limited role of fetal blood sampling in prediction of outcome in intrauterine growth retardation. Lancet. 1990;336:768–772
  16. Dawes GS. Pulmonary circulation in the foetus and new-born. Br. Med. Bull. 1966;22:61–65
  17. Skinner JR, Hunter S, Poets CF, et al.  Haemodynamic effects of altering arterial oxygen saturation in preterm infants with respiratory failure. Arch. Dis. Child. 1999;80:F81–F87
  18. Lacamp C, Walker S. Oxygen monitoring: too low or too high. National survey of oxygen saturation monitoring policies and the audit on the effect of change of policy in a single neonatal intensive unit. Early Hum Dev 2002 (Abstract, in press).
  19. Vijayakumar E, Ward GJ, Bullock CE, et al.  Pulse oximetry in infants <1500 gm at birth on supplemental oxygen: a national survey. J. Perinatol. 1997;17:341–345
  20. Tin W, Milligan DWA, Pennefather P et al. Pulse oximetry, severe retinopathy, and outcome at one year in babies of less than 28 weeks gestation. Arch Dis Child 2001; 84: F106–F110; see also F75–F76, F149–F150.
  21. OSIRIS Collaborative Group. Early versus delayed neonatal administration of a synthetic surfactant – the judgement of OSIRIS. Lancet 1992; 340: 1363–1369.
  22. Northern Neonatal Nursing Initiative Trial Group. Randomised trial of prophylactic early fresh-frozen plasma or gelatin or glucose in preterm babies: outcome at 2 years. Lancet 1996; 348: 229–232.
  23. Tin W, Fritz S, Wariyar U, et al.  Outcome of very preterm birth: children reviewed with ease at 2 years differ from those followed up with difficulty. Arch. Dis. Child. 1998;79:F83–F87
  24. Cryotherapy for Retinopathy of Prematurity Cooperative Group. Multicentre trial of cryotherapy for retinopathy of prematurity: one-year outcome – structure and function. Arch Ophthalmol 1990; 108: 1408–1416.
  25. The STOP-ROP Multicentre Study Group. Supplemental therapeutic oxygen for prethreshold retinopathy of prematurity (STOP-ROP), a randomised, controlled trial. Pediatrics 2000; 105: 295–319.
  26. Askie L, Henderson-Smark D, Irwig L, et al.  The effect of differing oxygen saturation targeting ranges on long term growth and development of extremely preterm, oxygen dependent infants: the BOOST trial. Pediatr. Res. 2002;51:378A
  27. Hay WW, Brockway JM, Eyzaquirre M. Neonatal pulse oximetry: accuracy and reliability. Pediatrics. 1989;83:717–722
  28. Brockway J, Hay WW. Prediction of arterial partial pressure of oxygen with pulse oxygen saturation measurements. J. Pediatr. 1998;133:63–66
  29. Thilo EH, Anderson D, Wasserstein ML, et al.  Saturation by pulse oximetry: comparison of the results obtained by instruments of different brands. J. Pediatr. 1993;122:620–626
  30. Moyle JTB. Pulse Oximetry. London: BMJ Books, 1994.

PII: S1526-0542(02)00307-X

doi: 10.1016/S1526-0542(02)00307-X

Paediatric Respiratory Reviews
Volume 4, Issue 1 , Pages 9-14 , March 2003

Article Tools

* Image Usage & Resolution